Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Flecainide 18.75mg/5ml oral liquid
0203020I0AAAPAP
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 1mg/5ml oral liquid
0203020I0AABNBN
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 2.5mg/5ml oral liquid
0203020I0AAAYAY
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 200mg/5ml oral liquid
0203020I0AAAXAX
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 20mg/5ml oral liquid
0203020I0AAAWAW
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 250mg/5ml oral liquid
0203020I0AABLBL
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 30mg/5ml oral liquid
0203020I0AABABA
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 33.33mg/5ml oral liquid
0203020I0AAAUAU
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 35mg/5ml oral liquid
0203020I0AABKBK
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 37.5mg/5ml oral liquid
0203020I0AABHBH
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 40mg/5ml oral liquid
0203020I0AABCBC
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 4mg/5ml oral liquid
0203020I0AABPBP
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 50mg/5ml oral liquid
0203020I0AAAQAQ
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 5mg/5ml oral liquid
0203020I0AAARAR
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 60mg/5ml oral liquid
0203020I0AABJBJ
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 65mg/5ml oral liquid
0203020I0AABGBG
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 6mg/5ml oral liquid
0203020I0AABDBD
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Flecainide 80mg/5ml oral liquid
0203020I0AABEBE
|
Flecainide acetate | Flecainide acetate | Cardiovascular System | No data available |
|
Fletchers Arachis oil 130ml enema
0106030A0BBAAAA
|
Fletchers Arach oil | Arachis oil | Gastro-Intestinal System | No data available |
|
Fletchers Enemette 5ml enema
0106020I0BDAAAG
|
Fletchers Enemette | Docusate sodium | Gastro-Intestinal System | No data available |
|
Fletchers phosphate enema 128ml long tube
0106040N0BBAAAA
|
Fletchers phosphate | Phosphates (Rectal) | Gastro-Intestinal System | No data available |
|
Fletchers phosphate enema 128ml standard tube
0106040N0BBABAB
|
Fletchers phosphate | Phosphates (Rectal) | Gastro-Intestinal System | No data available |
|
Flexeze capsules
1001050A0CEAAAQ
|
Flexeze (Glucosamine hydrochloride) | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Flexeze Double Strength tablets
091200000BFKBA0
|
Proprietary compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Flexi-melt Glucosamine hydrochloride 750mg tablets
1001050A0BGAAAE
|
Flexi-melt | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.